ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) today announced the launch of Vancomycin HCl 125mg and 250mg capsules, indicated for treatment of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE